This is the new MLex platform. Existing customers should continue to use the existing MLex platform until migrated.
For any queries, please contact Customer Services or your Account Manager. Dismiss

China's SAMR concluded 177 merger reviews in first quarter 2025

( April 16, 2025, 05:32 GMT | Official Statement) -- MLex Summary: China's top merger-control regulator concluded 177 merger reviews in the first quarter of 2025, unconditionally approving 174, while three cases were withdrawn. During the period, the number of unconditionally approved cases rose by 12 percent year-on-year, with domestic transactions particularly active. The manufacturing sector, notably in automotive and chemical raw materials, demonstrated impressive volume. The businesses involved in the deals originate from over 30 countries and regions worldwide, with foreign companies primarily from Germany, Japan and the US.The statement is attached. ...

Prepare for tomorrow’s regulatory change, today

MLex identifies risk to business wherever it emerges, with specialist reporters across the globe providing exclusive news and deep-dive analysis on the proposals, probes, enforcement actions and rulings that matter to your organization and clients, now and in the longer term.


Know what others in the room don’t, with features including:

  • Daily newsletters for Antitrust, M&A, Trade, Data Privacy & Security, Technology, AI and more
  • Custom alerts on specific filters including geographies, industries, topics and companies to suit your practice needs
  • Predictive analysis from expert journalists across North America, the UK and Europe, Latin America and Asia-Pacific
  • Curated case files bringing together news, analysis and source documents in a single timeline

Experience MLex today with a 14-day free trial.

Start Free Trial

Already a subscriber? Click here to login

Documents

Related Sections